Study
EORTC-1748-QLG-BCG-LYMG-GCG-GUCG
Phase 1-3 development of an EORTC module assessing fertility issues and patient care needs
Trial Status
Closed to Patient Entry
Dates
Date of activation: 01-Nov-2019
Data management at EORTC
None
Design
QoL Mod. development
Not randomized / N.A.
Not randomized / N.A.
Treatment
None
Study Staff
- Joachim Weis (Study Coordinator), Universitaetsklinikum Freiburg, Freiburg
- Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
Participating groups
- EORTC Breast Cancer Group
- EORTC Genito-Urinary Cancers Group
- EORTC Gynecological Cancer Group
- EORTC Lymphoma Group
- EORTC Quality of Life Group
- European Society for Gynecological Oncology